Finally, in PC patients, several clinical studies confirmed the correlation between poorer survival and increased IGF-1 serum concentrations, as well as low blood level of IGF-binding proteins (IGFBPs), supporting the role of IGF-1 signaling in this cancer [66,67,68]. This evidence concerns the gene IGF1 and pachyonychia congenita.